Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate and Hepatic dysfunction
Result of checking the interaction of drug Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate and disease Hepatic dysfunction for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of elvitegravir is not recommended for use in patients with severe hepatic impairment (Child-Pugh Class C). No dosage adjustment is required in patients with mild (Child-Pugh Class A) or moderate (Child-Pugh Class B) hepatic impairment.
Generic Name: cobicistat / elvitegravir / emtricitabine / tenofovir
Brand Name: Genvoya, Stribild
Synonyms: Cobicistat, elvitegravir, emtricitabine, and tenofovir